Sven Christian Engler, Stanislav Koulchitsky, Andelain Erickson, Tali Hoffmann, Idil Toklucu, Raya Bott, Jannis Körner, Ralf Hausmann, Karl Messlinger, Natja Haag, Justus P Beier, Robert Brunkhorst, Maike F Dohrn, Angelika Lampert, Roberto DeCol, Barbara Namer
{"title":"酚妥拉明选择性地阻断包括人类在内的不同物种的c纤维传导。","authors":"Sven Christian Engler, Stanislav Koulchitsky, Andelain Erickson, Tali Hoffmann, Idil Toklucu, Raya Bott, Jannis Körner, Ralf Hausmann, Karl Messlinger, Natja Haag, Justus P Beier, Robert Brunkhorst, Maike F Dohrn, Angelika Lampert, Roberto DeCol, Barbara Namer","doi":"10.1136/rapm-2025-106791","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Phentolamine is a non-selective competitive α-adrenergic antagonist clinically used to treat different vascular-related diseases. Since recent data suggest an antagonistic effect of phentolamine on voltage-gated sodium channels (VGSCs), further electrophysiological analysis is essential to understand its effects on peripheral sensory nerves.</p><p><strong>Methods: </strong>We examined the effects of phentolamine on the amplitude of the stimulus-evoked compound action potential (CAP) of A- and C-type nerve fibers derived from mice, pigs, and humans compared with the effects of lidocaine. To explore potential mechanisms of phentolamine action, we performed single nerve fiber recordings using skin-nerve preparations from wild-type and Na<sub>V</sub>1.8/Na<sub>V</sub>1.9 double knockout mice, along with manual and automated whole-cell patch-clamp electrophysiology on ND7/23 or HEK293 cells with heterologously expressed VGSCs.</p><p><strong>Results: </strong>Phentolamine decreased CAP amplitudes in a concentration-dependent manner, with significantly lower concentrations needed to affect C-fibers compared with A-fibers. Co-application of the α-adrenergic agonist (R)-(-)-phenylephrine did not alter this effect, suggesting that α-adrenergic receptors do not mediate phentolamine's action in this case. Phentolamine (100 µM) inhibited the electrically evoked action potentials (AP) in the majority of single-unit cutaneous C-fibers, while the same concentration did not provoke AP extinction in A-fibers. C-fibers from Na<sub>V</sub>1.8/Na<sub>V</sub>1.9 double knockout mice were significantly less sensitive to phentolamine than those from wild types. In patch-clamp experiments, phentolamine concentration-dependently blocked VGSCs, whereas Na<sub>V</sub>1.8 showed the highest sensitivity (IC<sub>50</sub>=10 µM).</p><p><strong>Conclusions: </strong>Suppressing AP conduction and inhibiting VGSCs, phentolamine exhibits features reminiscent of local anesthetics, but with a stronger effect on C-fibers, which may be attributed to its stronger action on tetrodotoxin-resistant VGSCs. However, due to its markedly higher affinity for α-adrenergic receptors compared with VGSCs, systemic administration of phentolamine is limited by its adrenergic side effects. These findings suggest that phentolamine could be useful for exploring C-fiber function and provide a basis for the development of more selective and potent antinociceptive agents.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phentolamine selectively blocks C-fiber conduction in different species, including humans.\",\"authors\":\"Sven Christian Engler, Stanislav Koulchitsky, Andelain Erickson, Tali Hoffmann, Idil Toklucu, Raya Bott, Jannis Körner, Ralf Hausmann, Karl Messlinger, Natja Haag, Justus P Beier, Robert Brunkhorst, Maike F Dohrn, Angelika Lampert, Roberto DeCol, Barbara Namer\",\"doi\":\"10.1136/rapm-2025-106791\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Phentolamine is a non-selective competitive α-adrenergic antagonist clinically used to treat different vascular-related diseases. Since recent data suggest an antagonistic effect of phentolamine on voltage-gated sodium channels (VGSCs), further electrophysiological analysis is essential to understand its effects on peripheral sensory nerves.</p><p><strong>Methods: </strong>We examined the effects of phentolamine on the amplitude of the stimulus-evoked compound action potential (CAP) of A- and C-type nerve fibers derived from mice, pigs, and humans compared with the effects of lidocaine. To explore potential mechanisms of phentolamine action, we performed single nerve fiber recordings using skin-nerve preparations from wild-type and Na<sub>V</sub>1.8/Na<sub>V</sub>1.9 double knockout mice, along with manual and automated whole-cell patch-clamp electrophysiology on ND7/23 or HEK293 cells with heterologously expressed VGSCs.</p><p><strong>Results: </strong>Phentolamine decreased CAP amplitudes in a concentration-dependent manner, with significantly lower concentrations needed to affect C-fibers compared with A-fibers. Co-application of the α-adrenergic agonist (R)-(-)-phenylephrine did not alter this effect, suggesting that α-adrenergic receptors do not mediate phentolamine's action in this case. Phentolamine (100 µM) inhibited the electrically evoked action potentials (AP) in the majority of single-unit cutaneous C-fibers, while the same concentration did not provoke AP extinction in A-fibers. C-fibers from Na<sub>V</sub>1.8/Na<sub>V</sub>1.9 double knockout mice were significantly less sensitive to phentolamine than those from wild types. In patch-clamp experiments, phentolamine concentration-dependently blocked VGSCs, whereas Na<sub>V</sub>1.8 showed the highest sensitivity (IC<sub>50</sub>=10 µM).</p><p><strong>Conclusions: </strong>Suppressing AP conduction and inhibiting VGSCs, phentolamine exhibits features reminiscent of local anesthetics, but with a stronger effect on C-fibers, which may be attributed to its stronger action on tetrodotoxin-resistant VGSCs. However, due to its markedly higher affinity for α-adrenergic receptors compared with VGSCs, systemic administration of phentolamine is limited by its adrenergic side effects. These findings suggest that phentolamine could be useful for exploring C-fiber function and provide a basis for the development of more selective and potent antinociceptive agents.</p>\",\"PeriodicalId\":54503,\"journal\":{\"name\":\"Regional Anesthesia and Pain Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regional Anesthesia and Pain Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/rapm-2025-106791\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regional Anesthesia and Pain Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/rapm-2025-106791","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
Phentolamine selectively blocks C-fiber conduction in different species, including humans.
Background: Phentolamine is a non-selective competitive α-adrenergic antagonist clinically used to treat different vascular-related diseases. Since recent data suggest an antagonistic effect of phentolamine on voltage-gated sodium channels (VGSCs), further electrophysiological analysis is essential to understand its effects on peripheral sensory nerves.
Methods: We examined the effects of phentolamine on the amplitude of the stimulus-evoked compound action potential (CAP) of A- and C-type nerve fibers derived from mice, pigs, and humans compared with the effects of lidocaine. To explore potential mechanisms of phentolamine action, we performed single nerve fiber recordings using skin-nerve preparations from wild-type and NaV1.8/NaV1.9 double knockout mice, along with manual and automated whole-cell patch-clamp electrophysiology on ND7/23 or HEK293 cells with heterologously expressed VGSCs.
Results: Phentolamine decreased CAP amplitudes in a concentration-dependent manner, with significantly lower concentrations needed to affect C-fibers compared with A-fibers. Co-application of the α-adrenergic agonist (R)-(-)-phenylephrine did not alter this effect, suggesting that α-adrenergic receptors do not mediate phentolamine's action in this case. Phentolamine (100 µM) inhibited the electrically evoked action potentials (AP) in the majority of single-unit cutaneous C-fibers, while the same concentration did not provoke AP extinction in A-fibers. C-fibers from NaV1.8/NaV1.9 double knockout mice were significantly less sensitive to phentolamine than those from wild types. In patch-clamp experiments, phentolamine concentration-dependently blocked VGSCs, whereas NaV1.8 showed the highest sensitivity (IC50=10 µM).
Conclusions: Suppressing AP conduction and inhibiting VGSCs, phentolamine exhibits features reminiscent of local anesthetics, but with a stronger effect on C-fibers, which may be attributed to its stronger action on tetrodotoxin-resistant VGSCs. However, due to its markedly higher affinity for α-adrenergic receptors compared with VGSCs, systemic administration of phentolamine is limited by its adrenergic side effects. These findings suggest that phentolamine could be useful for exploring C-fiber function and provide a basis for the development of more selective and potent antinociceptive agents.
期刊介绍:
Regional Anesthesia & Pain Medicine, the official publication of the American Society of Regional Anesthesia and Pain Medicine (ASRA), is a monthly journal that publishes peer-reviewed scientific and clinical studies to advance the understanding and clinical application of regional techniques for surgical anesthesia and postoperative analgesia. Coverage includes intraoperative regional techniques, perioperative pain, chronic pain, obstetric anesthesia, pediatric anesthesia, outcome studies, and complications.
Published for over thirty years, this respected journal also serves as the official publication of the European Society of Regional Anaesthesia and Pain Therapy (ESRA), the Asian and Oceanic Society of Regional Anesthesia (AOSRA), the Latin American Society of Regional Anesthesia (LASRA), the African Society for Regional Anesthesia (AFSRA), and the Academy of Regional Anaesthesia of India (AORA).